Metropolitan Life Insurance Company (MetLife)’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-21,285
| Closed | -$609K | – | 2600 |
|
|
2018
Q4 | $609K | Buy |
21,285
+280
| +1% | +$7.95K | 0.01% | 1079 |
|
|
2018
Q3 | $586K | Hold |
21,005
| – | – | 0.01% | 1248 |
|
|
2018
Q2 | $586K | Hold |
21,005
| – | – | 0.01% | 1204 |
|
|
2018
Q1 | $522K | Buy |
21,005
+515
| +3% | +$12.5K | 0.01% | 1245 |
|
|
2017
Q4 | $496K | Sell |
20,490
-23,142
| -53% | -$610K | 0.01% | 1297 |
|
|
2017
Q3 | $1.2M | Hold |
43,632
| – | – | 0.01% | 1147 |
|
|
2017
Q2 | $1.09M | Hold |
43,632
| – | – | 0.01% | 1192 |
|
|
2017
Q1 | $1.17M | Sell |
43,632
-995
| -2% | -$27.5K | 0.01% | 1155 |
|
|
2016
Q4 | $1.17M | Sell |
44,627
-1,075
| -2% | -$26.6K | 0.01% | 1218 |
|
|
2016
Q3 | $1.14M | Hold |
45,702
| – | – | 0.01% | 1210 |
|
|
2016
Q2 | $991K | Hold |
45,702
| – | – | 0.01% | 1260 |
|
|
2016
Q1 | $685K | Hold |
45,702
| – | – | 0.01% | 1392 |
|
|
2015
Q4 | $1M | Hold |
45,702
| – | – | 0.01% | 1189 |
|
|
2015
Q3 | $721K | Hold |
45,702
| – | – | 0.01% | 1385 |
|
|
2015
Q2 | $653K | Buy |
+45,702
| New | +$774K | ﹤0.01% | 1573 |
|
|
2015
Q1 | – | Sell |
-48,250
| Closed | -$865K | – | 2552 |
|
|
2014
Q4 | $865K | Hold |
48,250
| – | – | 0.01% | 1422 |
|
|
2014
Q3 | $634K | Hold |
48,250
| – | – | ﹤0.01% | 1565 |
|
|
2014
Q2 | $693K | Hold |
48,250
| – | – | ﹤0.01% | 1602 |
|
|
2014
Q1 | $615K | Hold |
48,250
| – | – | ﹤0.01% | 1661 |
|
|
2013
Q4 | $483K | Hold |
48,250
| – | – | ﹤0.01% | 1832 |
|
|
2013
Q3 | $635K | Hold |
48,250
| – | – | ﹤0.01% | 1592 |
|
|
2013
Q2 | $689K | Buy |
+48,250
| New | +$607K | 0.01% | 1485 |
|
Other funds holding NXTM
Metropolitan Life Insurance Company (MetLife)'s NXTM Position: Q1 2019 in Review
Metropolitan Life Insurance Company (MetLife) sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 21,285 shares — an estimated $609K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in NXTM in Q2 2013 and held it in 22 quarters. The position peaked at $1.2M in Q3 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Metropolitan Life Insurance Company (MetLife) reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 21,285 NxStage Medical Inc. shares in Q1 2019, an estimated $609K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 22 quarters.
- Metropolitan Life Insurance Company (MetLife)'s NxStage Medical Inc. position peaked at $1.2M in Q3 2017.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2019, filed 15 May 2019.